Global High-Priority Regulatory Events — February 17, 2026

18-02-2026

18-02-2026

18-02-2026

urban-gro, Inc. filed a Form 8-K on 2026-02-18 reporting entry into a Material Definitive Agreement under Item 1.01, Regulation FD Disclosure under Item 7.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement's nature, counterparties, financial terms, or impacts provided. No revenue, earnings, balance sheet effects, guidance changes, or other quantitative metrics are disclosed.

• ·File size: 1 MB
• ·Accession Number: 0001213900-26-017587
• ·Sector: NOT_DISCLOSED

18-02-2026

Mister Car Wash, Inc. filed a multi-item Form 8-K on February 18, 2026, disclosing Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 2.03 (Creation of a Direct Financial Obligation), Item 5.02 (Departure of Directors or Certain Officers; Election or Appointment), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, financial metrics, dollar values, period-over-period comparisons, or other quantitative data are disclosed in the provided filing summary. This appears to be a comprehensive voluntary and mandatory disclosure covering operational results, agreements, and governance matters.

18-02-2026

18-02-2026

18-02-2026

18-02-2026

Cannabist Co Holdings Inc. filed a Form 8-K on 2026-02-18 (AccNo: 0001776738-26-000004, size 131 KB) reporting under Item 1.01 its entry into a material definitive agreement. No details on the agreement's parties, terms, value, strategic rationale, or financial implications are disclosed. No quantitative metrics, positive or negative performance indicators, or forward-looking guidance are provided.

• ·AccNo: 0001776738-26-000004
• ·Event date aligns with filing date: 2026-02-18

18-02-2026

Gladstone Investment Corporation filed an 8-K on February 18, 2026, under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 reporting the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics are disclosed.

18-02-2026

18-02-2026

Zynex Inc filed an 8-K on 2026-02-18 (AccNo: 0001104659-26-017102, Size: 836 KB) reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, financial impacts, or metrics provided in the summary. No positive or negative financial metrics, period-over-period comparisons, or guidance changes were disclosed.

18-02-2026

Western Digital Corp filed a Form 8-K on 2026-02-18 under Item 3.03, disclosing material modifications to the rights of security holders. No specific details on the nature of the modifications, dollar values, financial impacts, or strategic rationale are provided. This requires review of the full filing for complete assessment.

18-02-2026

CareTrust REIT, Inc. filed a Form 8-K on 2026-02-18 disclosing entry into a material definitive agreement under Item 1.01, accompanied by financial statements and exhibits under Item 9.01. No specific details regarding the agreement's parties, terms, dollar value, strategic rationale, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics, period-over-period comparisons, or forward-looking guidance provided.

• ·Accession Number: 0001140361-26-005889
• ·Filing size: 845 KB

18-02-2026

SHARING ECONOMY INTERNATIONAL INC. filed an 8-K on February 18, 2026 (AccNo: 0001213900-26-017657), disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. Specific details including the key position affected, individual names, appointment or resignation status, reasons for change, and timing are NOT_DISCLOSED. No financial metrics, performance comparisons, or other quantitative data are provided in the filing summary.

• ·File size: 186 KB

18-02-2026

Bubblr Inc. filed a Form 8-K on 2026-02-18 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, dollar amounts, percentages, or other quantitative data disclosed. This represents a material negative event with no offsetting positive disclosures.

18-02-2026

Horizon Space Acquisition II Corp. filed an 8-K on 2026-02-18 disclosing Item 1.01 Entry into a Material Definitive Agreement related to a merger/acquisition, Item 5.03 Amendments to Articles of Incorporation or Bylaws or Change in Fiscal Year, Item 5.07 Submission of Matters to a Vote of Security Holders, and Item 9.01 Financial Statements and Exhibits. No quantitative metrics, deal terms, parties beyond the filer, valuations, or performance comparisons are explicitly stated. No positive or negative metrics are present to report.

18-02-2026

HF Sinclair Corp filed an 8-K on February 18, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the officer involved, position, reason for change, or any financial metrics are disclosed in the provided filing information. No positive or negative metrics, comparisons, or impacts are mentioned.

18-02-2026

Energy Vault Holdings, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001104659-26-016759), disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, financial impacts, or strategic context provided in the summary. No positive or negative metrics, period-over-period changes, or guidance revisions are disclosed.

18-02-2026

GLOBAL PAYMENTS INC filed an 8-K on 2026-02-18 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including position, appointment or resignation, reasons, financial metrics, or performance comparisons are NOT_DISCLOSED.

18-02-2026

Palladyne AI Corp. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, appointment or resignation status, reasons for change, or any financial metrics are disclosed. Sector not specified.

18-02-2026

18-02-2026

Granite Construction Inc filed an 8-K on February 18, 2026 (AccNo: 0000861459-26-000006), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 1.03 (Bankruptcy or Receivership), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses a core bankruptcy-related event with no specific financial metrics, transaction values, or quantitative impacts provided. No positive metrics were mentioned, highlighting severe financial distress.

18-02-2026

18-02-2026

CREATIVE REALITIES, INC. filed an 8-K on February 18, 2026 (AccNo: 0001437749-26-004453), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative metrics, period-over-period comparisons, or guidance changes are mentioned.

18-02-2026

Bread Financial Holdings, Inc. filed an 8-K on 2026-02-18 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 1.02 Termination of a Material Definitive Agreement. No financial details, transaction values, or impacts are disclosed. No quantitative metrics or period-over-period comparisons are provided.

18-02-2026

IMAC Holdings, Inc. filed an 8-K on February 18, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, or financial impacts are disclosed.

18-02-2026

Kraft Heinz Co filed an 8-K on February 18, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, nature of change (appointment or resignation), reasons, timing, or any quantitative data such as compensation amounts are disclosed in the provided filing information. No positive or negative governance implications, board outcomes, or market impacts can be assessed due to lack of details.

18-02-2026

Ankam, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any governance implications are NOT_DISCLOSED. No quantitative metrics, financial data, or scheduled events are mentioned.

18-02-2026

Madison Square Garden Sports Corp. filed an 8-K on February 18, 2026 (AccNo: 0001193125-26-056081, Size: 137 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected position, individuals involved, reasons for the change, or any quantitative metrics are disclosed. No positive or negative impacts are specified, resulting in neutral informational disclosure.

18-02-2026

TLGY Acquisition Corp filed an 8-K on 2026-02-18 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), related to a Merger/Acquisition event. No specific deal structure, parties involved, valuation, financial metrics, strategic rationale, or shareholder impacts are disclosed in the filing metadata provided. Sector details are not specified.

18-02-2026

i-80 Gold Corp. filed a Form 8-K on February 18, 2026, reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. Specific details regarding the nature of the agreement, disclosures, events, transaction values, financial impacts, or any quantitative metrics are NOT_DISCLOSED. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

18-02-2026

Theriva Biologics, Inc. filed an 8-K on 2026-02-18 disclosing entry into a material definitive agreement under Item 1.01 and Regulation FD disclosure under Item 7.01, with exhibits under Item 9.01. This is a multi-item mandatory and voluntary filing, but no details on the agreement's nature, parties, value, or financial impacts are provided in the available information. No quantitative metrics, positive or negative changes, or performance comparisons are disclosed.

• ·AccNo: 0001104659-26-016792
• ·Filing size: 677 KB

18-02-2026

Tarsus Pharmaceuticals, Inc. disclosed an officer change via 8-K filing on February 18, 2026, under Item 5.02 covering departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or terms are disclosed.

18-02-2026

Sensei Biotherapeutics, Inc. filed an 8-K on 2026-02-18 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). Additional disclosures include unregistered sales of equity securities (Item 3.02), departures or elections of directors and officers along with compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03). Regulation FD disclosure was provided (Item 7.01) with financial statements and exhibits (Item 9.01); no quantitative financial metrics, deal terms, or performance comparisons were detailed.

18-02-2026

Sintx Technologies, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, names, reasons, or timing were disclosed.

• ·AccNo: 0001493152-26-007271
• ·File Size: 367 KB
• ·Sector: NOT_DISCLOSED

18-02-2026

LIXTE BIOTECHNOLOGY HOLDINGS, INC. filed a Form 8-K on 2026-02-18 disclosing entry into a Material Definitive Agreement (Item 1.01), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). This is a multi-item filing with no specific details on the agreement's nature, parties, terms, financial impacts, or quantitative metrics provided. No performance metrics, positive or negative changes, or period-over-period comparisons were mentioned.

18-02-2026

La Rosa Holdings Corp. filed a Form 8-K on February 18, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific transaction details, dollar values, financial impacts, positive or negative metrics, or period-over-period comparisons are disclosed. This multi-item filing signals material developments but lacks quantitative context for assessment.

18-02-2026

Stardust Power Inc. filed a multi-item Form 8-K on February 18, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), and Regulation FD disclosure (Item 7.01), with exhibits under Item 9.01. No specific details on the agreement, transaction size, strategic rationale, or financial impacts are disclosed. The filing appears timely as it was submitted on the event date.

18-02-2026

Jaguar Health, Inc. filed a Form 8-K on February 18, 2026, reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the modifications, disclosures, events, or exhibits provided in the summary. No financial metrics, transactions, or performance data are disclosed.

18-02-2026

Health Catalyst, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation, reasons, or any quantitative metrics are provided. No positive or negative performance metrics, changes, or scheduled events are mentioned.

18-02-2026

Wealthfront Corp filed an 8-K on February 18, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's nature, parties, terms, financial impact, or strategic rationale are disclosed in the provided filing summary. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

18-02-2026

M Evo Global Acquisition Corp II filed an 8-K on 2026-02-18 disclosing other events under Item 8.01 in the context of a merger/acquisition, with Item 9.01 providing financial statements and exhibits. No specific deal structure, parties, financial metrics, or impacts are disclosed. No positive or negative metrics are present.

18-02-2026

Washington Trust Bancorp Inc filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the key position affected, individuals involved, reasons for the change, timing, or compensatory arrangements are disclosed in the provided information. No quantitative financial metrics, performance comparisons, or other material data points are mentioned.

• ·AccNo: 0000737468-26-000031
• ·File Size: 165 KB
• ·Sector: not specified

18-02-2026

Simulations Plus, Inc. filed an 8-K on February 18, 2026, reporting under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers; under Item 5.07 submission of matters to a vote of security holders; and under Item 9.01 financial statements and exhibits. No specific details such as names, titles, reasons for changes, timing, or quantitative impacts are disclosed. No positive or negative metrics, financial data, or scheduled events were mentioned.

18-02-2026

Ribbon Acquisition Corp. filed an 8-K on February 18, 2026, under Item 8.01 Other Events, disclosing a merger/acquisition event. No specific details on parties, deal structure, valuation, terms, or financial metrics are provided in the filing summary. Sector is not specified, limiting assessment of strategic or market implications.

18-02-2026

CENTRAL GARDEN & PET CO filed an 8-K on 2026-02-18 disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on the officer or director change, including key position, appointment/resignation status, reasons, timing, board composition impact, or vote outcomes, are NOT_DISCLOSED. No quantitative metrics, financial data, scheduled events, or governance implications are explicitly stated.

• ·AccNo: 0001193125-26-057026
• ·Filing size: 324 KB
• ·Event date: 2026-02-18

18-02-2026

Mondelez International, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001628280-26-009018), reporting multiple material events under Item 1.01 (entry into a material definitive agreement), Item 1.02 (termination of a material definitive agreement), Item 2.03 (creation of a direct financial obligation or off-balance sheet arrangement), and Item 9.01 (financial statements and exhibits). No quantitative details such as transaction values, financial impacts, or period-over-period comparisons are disclosed. This multi-item filing indicates significant contractual changes, but lacks specifics on nature, size, or strategic implications.

18-02-2026

Origin Materials, Inc. filed an 8-K on February 18, 2026, specifically under Item 5.07 disclosing Submission of Matters to a Vote of Security Holders. This is a standard informational filing reporting outcomes of a shareholder vote, with no financial metrics, vote results, or other quantitative data provided. No positive or negative performance indicators are mentioned.

18-02-2026

Equinix Inc (EQIX) filed an 8-K on February 18, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected position, individual names, reasons for change, or effective dates are disclosed in the provided filing summary.

18-02-2026

FormFactor Inc filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer's name, position, appointment or resignation status, reasons, or timing provided. No quantitative financial metrics, performance comparisons, or other material changes mentioned.

18-02-2026

Werner Enterprises Inc filed an 8-K on 2026-02-18 disclosing under Item 5.02 matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, names, reasons for changes, or quantitative impacts are provided.

• ·Filing Accession Number: 0000793074-26-000049
• ·File size: 167 KB
• ·Sector: not specified

18-02-2026

flyExclusive Inc. filed an 8-K on February 18, 2026, under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed.

18-02-2026

HCM IV Acquisition Corp. filed an 8-K on 2026-02-18 disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements and exhibits under Item 9.01. The filing relates to a merger/acquisition event but provides no specific details on parties, valuation, terms, or financial metrics. No quantitative data or performance comparisons are disclosed.

18-02-2026

Phio Pharmaceuticals Corp. filed a Form 8-K on February 18, 2026 (AccNo: 0001437749-26-004542), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, timing details, or quantitative data such as compensation amounts are disclosed in the provided filing summary. Sector is not specified.

18-02-2026

Remitly Global, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits are included. No specific details on the affected officer, position, appointment or resignation status, reasons, or timing are disclosed.

18-02-2026

YUNHONG GREEN CTI LTD. filed an 8-K on 2026-02-18 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names of individuals, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed. Sector information is not specified.

18-02-2026

RE/MAX Holdings, Inc. filed an 8-K on February 18, 2026, disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with no specific details on position, appointment/resignation, or reasons provided. The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No quantitative financial metrics, performance comparisons, or governance impacts are disclosed.

18-02-2026

Marchex Inc filed an 8-K on February 18, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on the agreement, transaction terms, personnel involved, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This is a multi-item mandatory filing with no mentioned positive or negative financial metrics.

18-02-2026

SM Energy Co filed an 8-K on 2026-02-18 reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No quantitative financial metrics, transaction details, positive or negative impacts, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item filing with no specifics on dollar values, strategic implications, or market effects.

18-02-2026

CIMG Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001493152-26-007338), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. The filing also includes Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific reasons for the delisting, financial impacts, dollar values, or other quantitative details are disclosed.

18-02-2026

RPC INC filed an 8-K on 2026-02-18 (AccNo: 0001104659-26-017066) under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions (e.g., CEO, CFO), names of individuals, appointment or resignation status, reasons for change, effective dates, or governance impacts are provided. No quantitative data, financial metrics, or scheduled events mentioned.

18-02-2026

T1 Energy Inc. filed an 8-K on 2026-02-18 reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties, financial terms, or impacts are disclosed. Filing accession number 0001213900-26-017944, size 257 KB.

• ·File size: 257 KB
• ·Accession Number: 0001213900-26-017944

18-02-2026

Greenlane Holdings, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on affected positions, individuals, reasons, or timing are disclosed.

18-02-2026

Etsy Inc filed a multi-item 8-K on February 18, 2026, reporting entry into a material definitive agreement under Item 1.01, results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific transaction details, financial metrics, period-over-period comparisons, or other quantitative data are disclosed in the provided filing summary. This appears to be a combined disclosure of a strategic agreement and financial results without further elaboration.

18-02-2026

ONE Gas, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for the change, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

18-02-2026

California BanCorp (CA) filed an 8-K on 2026-02-18 disclosing officer or director changes under Item 5.02, which covers departures, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific names, positions, reasons, financial metrics, or other quantitative details are disclosed.

18-02-2026

Array Technologies, Inc. filed a Form 8-K on February 18, 2026, disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, financial impacts, or performance metrics (positive, negative, or flat) are disclosed.

18-02-2026

Trulieve Cannabis Corp. filed an 8-K on 2026-02-18 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, timing, or any quantitative impacts are disclosed. This is a routine SEC disclosure for leadership changes with no additional context provided.

18-02-2026

INTEGRATED BIOPHARMA INC filed an 8-K on 2026-02-18 reporting entry into a material definitive agreement under Item 1.01. Item 9.01 discloses financial statements and exhibits. No transaction details, financial metrics, positive or negative impacts, or other quantitative data are provided.

18-02-2026

Warner Bros. Discovery, Inc. filed an 8-K on February 18, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, financial metrics, dollar values, positive or negative impacts, or performance comparisons are disclosed.

18-02-2026

Spring Valley Acquisition Corp. IV filed an 8-K on 2026-02-18 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a Merger/Acquisition event. No specific deal structure, parties involved beyond the filer, valuation, financial metrics, synergies, or regulatory details are disclosed in the provided filing information. This informational filing lacks quantitative data or directional performance indicators.

18-02-2026

Teladoc Health, Inc. filed an 8-K on 2026-02-18 disclosing an officer change or related matter under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), along with Regulation FD disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation status, reasons, or timing are disclosed. No financial metrics, performance comparisons, or quantitative data are mentioned.

18-02-2026

Gran Tierra Energy Inc. filed a multi-item 8-K on February 18, 2026, reporting entry into a new material definitive agreement (Item 1.01) while terminating a prior material definitive agreement (Item 1.02), alongside the creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03). Although the termination may relieve prior commitments, the new agreement and financial obligation introduce unknown balance sheet impacts. Item 9.01 provides financial statements and exhibits, but no transaction values, terms, or quantitative metrics were disclosed.

18-02-2026

RF Acquisition Corp III filed an 8-K on 2026-02-18 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition. The filing also covers unregistered sales of equity securities (Item 3.02), departures or elections of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific deal terms, financial metrics, positives, negatives, or performance comparisons are disclosed.

18-02-2026

ITT Inc. filed an 8-K on February 18, 2026 (AccNo: 0000216228-26-000018), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or other metrics are disclosed.

18-02-2026

Sky Harbour Group Corp filed an 8-K on 2026-02-18 disclosing entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement under Item 2.03. Item 9.01 provides Financial Statements and Exhibits. No quantitative details, transaction terms, dollar values, or financial impacts are disclosed.

18-02-2026

LiveRamp Holdings, Inc. filed an 8-K on 2026-02-18 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative terms are disclosed in the provided filing information. This is a routine governance disclosure with no additional financial or operational metrics mentioned.

18-02-2026

M3-Brigade Acquisition V Corp. filed an 8-K on February 18, 2026, announcing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. The filing includes financial statements and exhibits under Item 9.01. No specific transaction parties, deal terms, valuations, or financial metrics are disclosed.

18-02-2026

Coeur Mining, Inc. filed an 8-K on February 18, 2026 (AccNo: 0001140361-26-006019, Size: 23 MB), triggering Items 2.02 (Results of Operations and Financial Condition), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the officer change, including position, name, reason, appointment/resignation status, financial metrics, or results of operations are disclosed in the provided information. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

18-02-2026

LIQTECH INTERNATIONAL INC filed an 8-K on 2026-02-18 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for the change, and any timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

18-02-2026

Conagra Brands Inc. filed an 8-K on February 18, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics are disclosed in the provided information.

18-02-2026

Iris Acquisition Corp II filed an 8-K on 2026-02-18 (AccNo: 0001185185-26-000610, Size: 268 KB) under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a Merger/Acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, or strategic rationale are disclosed in the provided filing summary. Sector is not specified.

• ·AccNo: 0001185185-26-000610
• ·Filing size: 268 KB
• ·Sector: not specified

18-02-2026

Charles River Laboratories International, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officers, reasons for change, or quantitative impacts are disclosed.

18-02-2026

LanzaTech Global, Inc. filed an 8-K on 2026-02-18 (AccNo: 0001628280-26-009171, Size: 199 KB) disclosing under Item 1.01 entry into a Material Definitive Agreement. No details on the agreement's nature, parties, dollar value, financial impacts, or strategic context were provided. This appears to be a single-item mandatory filing with sector not specified.

18-02-2026

MVB Financial Corp filed an 8-K on February 18, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any financial metrics are disclosed. The filing appears routine with no quantified positive or negative impacts mentioned.

18-02-2026

Cartica Acquisition Corp filed an 8-K on 2026-02-18 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. Item 8.01 reports other events, with no further details provided. No quantitative metrics, deal terms, or positive developments are mentioned, indicating potential liquidity and compliance risks for shareholders.

18-02-2026

ARKO Corp. filed an 8-K on 2026-02-18 reporting Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing, but specific details on the agreement, transaction terms, financial impacts, or dollar values are NOT_DISCLOSED. No quantitative metrics, guidance changes, or scheduled events were provided.

18-02-2026

RLJ Lodging Trust filed an 8-K on February 18, 2026, under Item 1.01 disclosing entry into a material definitive agreement and Item 2.03 announcing the creation of a direct financial obligation or off-balance sheet arrangement. Item 8.01 reports other events, while Item 9.01 lists financial statements and exhibits. No specific transaction details, financial metrics, or impacts were disclosed.

18-02-2026

Outlook Therapeutics, Inc. filed an 8-K on 2026-02-18 under Item 3.01, announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, or additional details such as reasons for delisting, impacts, or related events were disclosed.

18-02-2026

Avalon GloboCare Corp. filed an 8-K on February 18, 2026, reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and 3.02 (Unregistered Sales of Equity Securities), with Item 9.01 listing Financial Statements and Exhibits. While the material definitive agreement may indicate strategic developments, the financial obligation and unregistered equity sales could imply increased leverage or shareholder dilution. No specific transaction details, dollar values, terms, or financial metrics are disclosed.

18-02-2026

AMERICAN FINANCIAL GROUP INC filed an 8-K on 2026-02-18 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on individuals, positions, reasons, or quantitative impacts are disclosed.

18-02-2026

Chain Bridge I filed a Form 8-K on February 18, 2026 (AccNo: 0001213900-26-018000), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. This event indicates potential removal from US exchange listing with no additional financial metrics, impacts, or reasons disclosed. Sector not specified.

18-02-2026

Jaguar Uranium Corp. filed an 8-K on February 18, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also covers Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on positions affected, individuals involved, reasons for changes, or financial metrics are disclosed.

18-02-2026

ARKO Petroleum Corp. filed an 8-K on February 18, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 discloses financial statements and exhibits. No quantitative metrics, dollar values, period-over-period changes, or specific transaction details are provided.

18-02-2026

OneMeta Inc. filed a Form 8-K on 2026-02-18 reporting entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03. Item 9.01 discloses Financial Statements and Exhibits. No specific transaction details, dollar values, financial impacts, or other metrics are provided.

18-02-2026

CNX Resources Corp filed an 8-K on February 18, 2026 (AccNo: 0001193125-26-057453), reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. Specific details of the material agreement, disclosures, transaction value, financial impacts, or any metrics are NOT_DISCLOSED in the provided filing summary. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

• ·Multi-item 8-K filing including mandatory Item 1.01 for material definitive agreement

18-02-2026

Atlassian Corp filed an 8-K on 2026-02-18 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or effective dates are disclosed. No quantitative metrics, financial impacts, or performance comparisons are mentioned.

18-02-2026

Core Scientific, Inc. filed a Form 8-K on February 18, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, with Item 9.01 providing financial statements and exhibits. No quantitative metrics, transaction details, personnel names, dollar values, or performance comparisons (positive, negative, or flat) are disclosed. This is a multi-item filing focused on material events without specified financial impacts.

18-02-2026

Trailblazer Merger Corp I filed an 8-K on 2026-02-18 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. Item 9.01 provides for financial statements and exhibits. No specific transaction parties, deal terms, valuations, financial metrics, or performance comparisons are disclosed in the provided filing information.

18-02-2026

SmartStop Self Storage REIT, Inc. filed a Form 8-K on 2026-02-18 reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No quantitative details such as transaction value, financial impacts, or specific terms are disclosed.

18-02-2026

Liminatus Pharma, Inc. filed a Form 8-K on February 18, 2026, disclosing entry into a Material Definitive Agreement under Item 1.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific details regarding the agreement, events, transaction value, financial impacts, or quantitative metrics are provided in the filing summary. This is a multi-item mandatory disclosure for Item 1.01 with potential voluntary elements in Item 8.01.

• ·Accession Number: 0001104659-26-017134
• ·Filing size: 942 KB
• ·Multi-item 8-K (Items 1.01, 8.01, 9.01)

18-02-2026

NewMarket Corp filed an 8-K on 2026-02-18 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, timing, or any quantitative data are disclosed. No positive or negative metrics, financial impacts, or governance implications are provided in the filing summary.

18-02-2026

ALTISOURCE PORTFOLIO SOLUTIONS S.A. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Other Events (Item 8.01). Specific details including the key position affected, whether it is an appointment or resignation, the officer's name, reason for change, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

18-02-2026

Nuburu, Inc. filed a multi-item Form 8-K on February 18, 2026, disclosing entry into a material definitive agreement (Item 1.01), notice of delisting or failure to satisfy a continued listing rule or standard (Item 3.01), material modifications to rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements and exhibits (Item 9.01). The inclusion of Item 3.01 signals potential delisting risks, which is negative for liquidity and valuation, while Item 1.01 indicates an undisclosed material agreement whose impact is unknown. No quantitative financial metrics, transaction values, or specific details are provided.

18-02-2026

SAFE & GREEN HOLDINGS CORP. filed a Form 8-K on February 18, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, personnel names, dollar values, or performance comparisons (positive, negative, or flat) are disclosed in the provided filing summary.

18-02-2026

JFB Construction Holdings filed a multi-item Form 8-K on February 18, 2026, reporting entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details, transaction values, financial impacts, personnel names, or quantitative metrics are disclosed in the provided filing summary. This mandatory disclosure signals potentially significant developments but lacks substance for directional assessment.

18-02-2026

RESEARCH FRONTIERS INC filed an 8-K on February 18, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or performance metrics are provided.